Tuberculosis subunit vaccine (University of Oxford)

N/A

Report date: 2026/05/24 20:00:34

Base Information

Drug NameTuberculosis subunit vaccine (University of Oxford)
Drug Alias Name结核亚单位疫苗 - 结核亚单位疫苗Tuberculosis vaccine (University of Oxford)MVA-85-AIMX-313AERAS4-85MVA-85A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHIV InfectionsTuberculosis, PulmonaryTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUgandaSenegalSouth Africa +[5
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Oxford
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Oxford
Active IndicationsN/A
Inactive IndicationsHIV InfectionsTuberculosis, PulmonaryTuberculosis

Other Information

ATC CodeN/A
Related LinksN/A